Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center

Familial Cancer

Volumn 10, Issue 4, 2011, Pages 673-679

  Ready, K ^a   Arun, B K ^a   Schmeler, K M ^a   Uyei, A ^b   Litton, J K ^a   Lu, K H ^a   Sun, C C ^a   Peterson, S K ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BRCA1; BRCA2; Communication; Genetic testing; Health care providers; Test results

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; COMMUNICATION SKILL; CONTROLLED STUDY; EDUCATION; FEMALE; GENETIC ANALYSIS; GENETIC COUNSELING; HEALTH CARE PERSONNEL; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PERCEPTION; POINT MUTATION; PRIORITY JOURNAL; QUESTIONNAIRE; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC TESTING; HEALTH PERSONNEL; HUMANS; INFORMATION DISSEMINATION; NEOPLASTIC SYNDROMES, HEREDITARY; PROFESSIONAL-PATIENT RELATIONS; RISK ASSESSMENT;

EID: 84855646599     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-011-9460-z     Document Type: Article

References (37)

1. Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329-1333 (Pubitemid 46706879)
2. Ford D, Easton DF, Bishop DT et al (1994) Risks of cancer in BRCA1-mutation carriers. Breast cancer linkage consortium. Lancet 343:692-695 (Pubitemid 24087847)
3. Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62:676-689 (Pubitemid 28164626)
4. Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75-89 (Pubitemid 46535708)
5. King MC, Wieand S, Hale K et al (2001) Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) breast cancer prevention trial. JAMA 286:2251-2256 (Pubitemid 33063147)
6. Narod SA, Brunet JS, Ghadirian P et al (2000) Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: A case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet 356:1876-1881
7. Antoniou AC, Rookus M, Andrieu N et al (2009) Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: Results from the International BRCA1/ 2 Carrier Cohort Study. Cancer Epidemiol Biomarkers Prev 18:601-610
8. McLaughlin JR, Risch HA, Lubinski J et al (2007) Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: A case-control study. Lancet Oncol 8:26-34 (Pubitemid 46001033)
9. Hartmann LC, Sellers TA, Schaid DJ et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93:1633-1637 (Pubitemid 33094870)
10. Meijers-Heijboer H, van Geel B, van Putten WL et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345:159-164 (Pubitemid 32662123)
11. Rebbeck TR, Friebel T, Lynch HT et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group. J Clin Oncol 22:1055-1062 (Pubitemid 41095038)
12. Kauff ND, Satagopan JM, Robson ME et al (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346:1609-1615 (Pubitemid 34755668)
13. Rebbeck TR, Levin AM, Eisen A et al (1999) Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 91:1475-1479 (Pubitemid 29424552)
14. Rebbeck TR, Lynch HT, Neuhausen SL et al (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346:1616-1622 (Pubitemid 34755669)
15. Olopade OI, Artioli G (2004) Efficacy of risk-reducing salpingooophorectomy in women with BRCA-1 and BRCA-2 mutations. Breast J 10(Suppl 1):5-9
16. Kurian AW, Sigal BM, Plevritis SK (2009) Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Clin Oncol 28:222-231
17. McInerney JD (2008) Genetics education for health professionals: A context. J Genet Couns 17:145-151 (Pubitemid 351362199)
18. ACOG Practice Bulletin No. 103 (2009) Hereditary breast and ovarian cancer syndrome. Obstet Gynecol 113:957-966
19. NCCN Clinical Practice Guidelines. Genetic/Familial High-Risk Assessment: Breast and Ovarian (2009) www.nccn.org. Retrieved 10 Jan 2010
20. Nelson HD, Huffman LH, Fu R et al (2005) Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Systematic evidence review for the US preventive services task force. Ann Intern Med 143:362-379
21. Lancaster JM, Powell CB, Kauff ND et al (2007) Society of gynecologic oncologists education committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol 107:159-162 (Pubitemid 47575743)
22. Acton RT, Burst NM, Casebeer L et al (2000) Knowledge, attitudes, and behaviors of Alabama's primary care physicians regarding cancer genetics. Acad Med 75:850-852 (Pubitemid 30644975)
23. Freedman AN, Wideroff L, Olson L et al (2003) US physicians' attitudes toward genetic testing for cancer susceptibility. Am J Med Genet A 120A:63-71 (Pubitemid 37063834)
24. Pichert G, Dietrich D, Moosmann P et al (2003) Swiss primary care physicians' knowledge, attitudes and perception towards genetic testing for hereditary breast cancer. Fam Cancer 2: 153-158 (Pubitemid 38017037)
25. Escher M, Sappino AP (2000) Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition. Ann Oncol 11:1131-1135
26. Armstrong K, Stopfer J, Calzone K et al (2002) What does my doctor think? Preferences for knowing the doctor's opinion among women considering clinical testing for BRCA1/2 mutations. Genet Test 6:115-118
27. Tinley ST, Houfek J, Watson P et al (2004) Screening adherence in BRCA1/2 families is associated with primary physicians' behavior. Am J Med Genet A 125A:5-11 (Pubitemid 38166526)
28. Uyei A, Peterson SK, Erlichman J et al (2006) Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: A singleinstitution study. Cancer 107:2745-2751 (Pubitemid 44937026)
29. Litton JK, Westin SN, Ready K et al (2009) Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation. Cancer 115:1598-1604
30. Morgan D, Sylvester H, Lucas FL et al (2010) Hereditary breast and ovarian cancer: Referral source for genetic assessment and communication regarding assessment with nongenetic clinicians in the community setting. Genet Med 12:25-31
31. Cheung WY, Neville BA, Cameron DB et al (2009) Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol 27:2489-2495
32. Hall MA, McEwen JE, Barton JC et al (2005) Concerns in a primary care population about genetic discrimination by insurers. Genet Med 7:311-316 (Pubitemid 40827579)
33. Rowley PT, Loader S (1996) Attitudes of obstetrician-gynecologists toward DNA testing for a genetic susceptibility to breast cancer. Obstet Gynecol 88:611-615 (Pubitemid 26326028)
34. Barrison AF, Smith C, Oviedo J et al (2003) Colorectal cancer screening and familial risk: A survey of internal medicine residents' knowledge and practice patterns.AmJ Gastroenterol 98:1410-1416 (Pubitemid 36741542)
35. Blazer KR, Grant M, Sand SR et al (2004) Effects of a cancer genetics education programme on clinician knowledge and practice. J Med Genet 41:518-522 (Pubitemid 38932111)
36. Schroy PC 3rd, Barrison AF, Ling BS et al (2002) Family history and colorectal cancer screening: A survey of physician knowledge and practice patterns. Am J Gastroenterol 97:1031-1036 (Pubitemid 34408265)
37. Offit K, Greene MH (2004) ASCO curriculum: Cancer genetics and cancer predisposition testing, 2nd edn. ASCO Publishing, Alexandria, VA